Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.

Mogul HR, Lee PD, Whitman BY, Zipf WB, Frey M, Myers S, Cahan M, Pinyerd B, Southren AL.

J Clin Endocrinol Metab. 2008 Apr;93(4):1238-45. doi: 10.1210/jc.2007-2212. Epub 2008 Jan 22.

PMID:
18211968
2.

Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.

Höybye C, Hilding A, Jacobsson H, Thorén M.

Clin Endocrinol (Oxf). 2003 May;58(5):653-61.

PMID:
12699450
3.

Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C.

Endocrine. 2012 Apr;41(2):191-9. doi: 10.1007/s12020-011-9560-4. Epub 2011 Nov 12. Review.

PMID:
22081257
4.

Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.

de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2009 Nov;94(11):4205-15. doi: 10.1210/jc.2009-0454. Epub 2009 Oct 16.

PMID:
19837938
5.
6.
8.
10.
11.

Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study.

Jørgensen AP, Ueland T, Sode-Carlsen R, Schreiner T, Rabben KF, Farholt S, Høybye C, Christiansen JS, Bollerslev J.

Growth Horm IGF Res. 2014 Feb;24(1):16-21. doi: 10.1016/j.ghir.2013.11.002. Epub 2013 Dec 4.

PMID:
24360789
12.

Somatropin therapy in adults with Prader-Willi syndrome.

Höybye C, Thorén M.

Treat Endocrinol. 2004;3(3):153-60. Review.

PMID:
16026111
13.

Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.

Bakker NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Schroor EJ, Van Alfen AA, Van Leeuwen M, Van Pinxteren-Nagler E, Van Wieringen H, Vreuls RC, Zwaveling-Soonawala N, de Ridder MA, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2013 Oct;98(10):4013-22. doi: 10.1210/jc.2013-2012. Epub 2013 Sep 3.

PMID:
24001750
14.

The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.

Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen RA, Grunfeld C, Schambelan M.

J Clin Endocrinol Metab. 2001 Aug;86(8):3480-7.

PMID:
11502767
15.

Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment.

de Lind van Wijngaarden RF, Cianflone K, Gao Y, Leunissen RW, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2010 Apr;95(4):1758-66. doi: 10.1210/jc.2009-0656. Epub 2010 Feb 19.

PMID:
20173020
16.

Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.

Festen DA, van Toorenenbergen A, Duivenvoorden HJ, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2007 Apr;92(4):1549-54. Epub 2007 Jan 30.

PMID:
17264186
17.

Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.

Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB.

J Clin Endocrinol Metab. 2010 Mar;95(3):1131-6. doi: 10.1210/jc.2009-1389. Epub 2010 Jan 8.

18.

Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C.

Growth Horm IGF Res. 2011 Aug;21(4):185-90. doi: 10.1016/j.ghir.2011.05.002. Epub 2011 Jun 12.

PMID:
21664161
19.

Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.

Coupaye M, Lorenzini F, Lloret-Linares C, Molinas C, Pinto G, Diene G, Mimoun E, Demeer G, Labrousse F, Jauregi J, Laurier V, Basdevant A, Polak M, Thuilleaux D, Tauber M, Poitou C.

J Clin Endocrinol Metab. 2013 Feb;98(2):E328-35. doi: 10.1210/jc.2012-2881. Epub 2013 Jan 2.

PMID:
23284006
20.

Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.

Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2008 Sep;69(3):443-51. doi: 10.1111/j.1365-2265.2008.03228.x. Epub 2008 Mar 18.

PMID:
18363884
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk